Insider Trading Arrangements - Joseph Monahan

3 Months Ended

Dec. 31, 2024

shares

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

On December 12, 2024, Joseph Monahan, our Chief Scientific Officer, adopted a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. Sales may commence under the plan on March 13, 2025 and the plan terminates on December 31, 2025, subject to earlier termination in accordance with its terms. The aggregate number of securities to be sold under the plan is 60,000 shares of common stock.

Name

Joseph Monahan

Title

Chief Scientific Officer

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

December 12, 2024

Rule 10b5-1 Arrangement Terminated

true

Termination Date

December 31, 2025

Aggregate Available

60,000